Some second dose appointments offered to teenagers in error

NHS Lothian has said that a number of second vaccination appointments have been mistakenly scheduled for 16 and 17-year-olds.

The health board said text message and appointment letters have been issued to the teenagers in Lothian which urge them to attend an appointment for a second dose of COVID vaccine, even though they may not be eligible.

At the moment, and in line with national guidance, 16 and 17-year-olds are only being offered one dose of the vaccine, unless they are clinically extremely vulnerable themselves, living with someone who is or are an unpaid carer.

However a data error has caused 2,500 text messages to be sent to teenagers in Lothian inviting them for a second dose. Many of those invitations may be entirely appropriate, but many will not.

As a result, a second text message has been issued urging the teenagers not to attend unless they are clinically extremely vulnerable themselves, living with someone who is or are an unpaid carer.

The situation is under investigation to establish what happened and how many letters may also have been sent via the national booking system to teenagers.

Pat Wynne, Director of Nursing Primary and Community Care, NHS Lothian, said: “I would like to apologise to all of those teenagers affected and for any confusion and inconvenience caused.

“All of those who received a text message have been contacted again with more information on what to do next. We don’t yet know how many letters have been issued, but we are investigating fully to establish what happened and how many people are affected.

“If you are eligible for a second dose – if you clinically extremely vulnerable yourself, living with someone else who is or are an unpaid carer – please double-check your appointment and make sure you receive that vital protection from a second dose.

“However we are really keen to make sure that other teenagers do not face a wasted journey to a vaccination centre or that they do not receive a second dose when it is currently not recommended for them.”

Vaccine certification scheme comes into effect today

Proof of status now needed at higher risk venues

The Coronavirus vaccine certification scheme comes into effect today in Scotland meaning people will have to show proof  of their vaccination status to  enter some events and higher risk venues.

People attending a range of  late night venues and larger  indoor and outdoor live events, such as music festivals or large sporting events, will be required to show staff their Covid status. This can be done via the NHS Scotland Covid Status App released yesterday on their mobile device or using the paper certificate.

Following consultation with businesses affected a grace period has been agreed until Monday October 18th before the scheme is legally enforced. The legal requirement for businesses to keep information about certification status confidential and not use it for other purposes comes into effect today.

Deputy First Minister John Swinney said:  “We know from expert public health analysis that we must do all we can to stem the rise in cases and reduce the pressure on the NHS.

“Vaccine certificates have a role to play as part of a wider package of measures. They add a further layer of protection in certain higher risk settings.

“This is a very limited scheme and we hope this will allow businesses to remain open and prevent any further restrictions as we head into autumn and winter.

“I would encourage people to to download the NHS Scotland Covid Status App and help our drive to keep the virus under control.

“Scotland is not unique in introducing such an approach. Certification schemes are in place across Europe, including Ireland and France, and the Welsh Government is also planning similar measures.

“I also want to ensure that as many people get vaccinated as possible and particularly to increase uptake in the younger age cohort, so anything that helps to incentivise that is helpful.”

The Scottish Government will continue to work with the sectors affected and updated guidance has been published to help ensure the smooth introduction of the scheme.

People in Scotland can download the NHS Scotland Covid Status App via their mobile device. A  paper certificate or the downloadable PDF is also available from NHS Inform. 

The Regulations which came into force at 5am today and must be reviewed every three weeks as part of the wider review of Coronavirus Regulations.

There are currently no plans to introduce certification for the wider hospitality industry but this will be kept under review over the autumn and winter months.

Exemptions to the scheme include under 18s, participants in vaccine trials, as well as people who cannot be vaccinated for medical reasons and people working or performing in the venues.

Officials are currently working with other UK jurisdictions to help ensure people vaccinated outside Scotland can still enter the venues affected with proof of their vaccine status.

The NHS Scotland Covid Status App is available for download from NHS Inform: 

NHS Scotland COVID Status | NHS inform

Businesses can use the free NHS Scotland Covid Check App to verify the QR codes on official Covid Certificates: 

www.covidcheck.scot

Vaccinations programme makes ‘excellent progress’, says Audit Scotland report

The Covid-19 vaccination programme has made excellent progress in vaccinating a large majority of the adult population in Scotland, according to a new report published today (30 September) by Audit Scotland.

By 17 September, more than 90 per cent of people aged 18 or over had received at least one Covid-19 vaccine. Levels of vaccine wastage have been low, and the programme has helped reduce the number of people getting severely ill and dying.

However, uptake has been lower amongst young people, those in the most deprived areas and those from some ethnic minority backgrounds.

The vaccine rollout has also relied on a temporary staff drawn from across the NHS. This is an expensive model and the Scottish Government recognises that it needs a longer-term solution.

NHS boards and health and social care partnerships currently expect vaccine delivery costs to be around £223 million in 2021/22. But the final cost for this year will depend on clinical advice issued by the Joint Committee on Vaccination and Immunisation, so it could differ substantially from the current estimate.

Stephen Boyle, Auditor General for Scotland, said: “The delivery of the vaccination programme has been a success so far, with good collaboration and new digital tools developed to help the process.

“Early scenario planning by the Scottish Government and NHS boards has allowed them to continue to react quickly to formal UK clinical advice.

“There is now an opportunity for the Scottish Government to use what’s it’s learned to manage the challenges of the next part of the vaccine programme, and the wider delivery of NHS services.”

Covid Vaccination appointments for 12-15 year olds: letters sent out

Letters offering a coronavirus (COVID-19) vaccination to all 12-15 year olds who haven’t yet received their jab are arriving from today (Monday).  

Drop-in clinics have been available to this age group for the last week and now scheduled appointments – starting this week – are being issued to all those eligible. The letters will contain an information leaflet, which all parents and carers should read with their children so they can make an informed decision about getting the vaccine. This information is also available online at NHS Inform.

Parents and carers are encouraged to accompany their children to community-based appointments where possible so any questions they may have can be raised with staff on site.

In some rural areas, this age group will be offered the jabs through their school vaccination programme instead of a community setting and they will receive letters and leaflets home from school. In these situations, parents and carers who have questions they wish to discuss with a vaccinator before the school session can go to any drop-in clinic and ask for advice.  

Health Secretary Humza Yousaf said: “The roll out of the COVID-19 vaccine to all children and young people aged 12-15 marks a significant milestone in the vaccination programme.

“It has been demonstrated that COVID-19 vaccines are safe and effective in this age group, and vaccination offers the best chance of protecting young people from COVID-19 and preventing further disruption to education. Many countries around the world have already been safely vaccinating children and young people in this age group.

“Getting the COVID-19 vaccine is a decision to be made jointly between parents or carers and their children, but it’s really important to use reliable and trusted sources such as NHS Inform when making a decision and assessing the potential benefits, risks and side effects.  Individual choice should be respected for the decisions young people and their parents or carers make in accepting, or not accepting the vaccine offer.

“Where possible, parents or carers are welcome to attend appointments with their children and both can ask questions about any queries they have before the vaccination is given.

“I would like to thank all of the vaccinators and vaccine site staff who have worked so hard to get us to this stage of the COVID-19 vaccine programme.”

Children aged 12-15 who have specific underlying conditions or disabilities are already covered by previous JCVI advice and will be offered two doses of the vaccine, eight weeks apart.

Vaccinating 12 to 15 year olds | NHS inform

Drop-in clinics

Vaccination drive accelerated

Covid-19 booster vaccinations get underway today

– Lothian launches drop-in clinics for 12 to 15-year-olds

Residents in care homes for older people are the first to be offered coronavirus (COVID-19) booster vaccinations from today (Monday).

This group will be offered both flu and COVID-19 booster vaccines after the Joint Committee on Vaccination and Immunisation advised that they could be given alongside one another.

From tomorrow (Tuesday 21 September) frontline health and social care workers are able to book an appointment for a booster jab online at NHS Inform. The portal can be used by all health and social care workers to book a flu vaccine.

Adults aged 70 years and over and those 16 years and over who are on the highest risk list (previously known as the shielding list) will begin to be contacted by letter or by their GP from the end of September.  

People on the highest risk list who were severely immunosuppressed at the time of their last COVID-19 vaccination will be offered a third primary dose instead. 

Other eligible groups – including all those aged 16 to 49 years with underlying health conditions, adult carers, unpaid and young carers, adult household contacts of immunosuppressed individuals and all adults over 50 – will be able to book an appointment online from October.

Meanwhile, also from today (Monday) children and young people aged 12 -15 years old can go to drop-in clinics for a vaccination if they wish to get their jab before they receive their letter inviting them for a scheduled appointment. Everyone in this age group will be invited for vaccination at a community based clinic or a school delivery session from 27 September.

Heath Secretary Humza Yousaf said: “I am pleased to see the booster programme getting underway for residents in care homes for older people, offering longer lasting protection against severe COVID-19 illness.

“The booster programme will run alongside our biggest ever flu vaccine programme as both of these programmes are important for individual and for public health and wherever possible, those eligible will be offered COVID-19 booster and flu vaccines together.

“We are also starting vaccination of 12-15 year olds after Scottish Ministers accepted advice from the four UK Chief Medical Officers. This group can now head to drop-in clinics for their jabs or wait for a letter offering them a scheduled appointment.”

NHS Lothian launches drop-in clinics for 12 to 15-year-olds

Young people aged 12 to 15 will be able to get a COVID-19 vaccine at drop-in clinics across Lothian from today (September 20).

Mass clinics in West Lothian, Edinburgh and Midlothian will open their doors to young people as part of the latest phase of the national vaccination programme.

Pyramids, Gorebridge and Lowland Hall vaccination clinics will be the first in Lothian to administer the lifesaving vaccine, before more clinics are added to the list over coming days.

Pat Wynne, Director of Nursing for Primary and Community Care, NHS Lothian said: “We are delighted to offer drop-in clinics for young people aged 12-15.

“These clinics will enable young people to attend, without a prior appointment to receive their vaccination.

“We recognise that young people, as well as their parents and guardians may have questions regarding the COVID vaccination and we encourage them to visit the pages on NHS Inform where there is a range of information available.

“Alongside this, our teams at Pyramids, Gorebridge and Lowland Hall are one hand to answer any questions people may have.

“Vaccination remains critically important in the continued fight against COVID-19 and we welcome the further expansion of the vaccination programme across Lothian.”

The clinics are opening their doors following the publication and government acceptance of the advice of the four Chief Medical Officers (CMOs) to offer a single dose of the COVID vaccine to all healthy 12-15-year-olds.

Young people do not need to be registered with a GP to attend, however it is requested that they are accompanied by their parent or guardian.

As well as the drop-in clinics for 12-15’s, NHS Lothian continues to operate a range of COVID vaccination clinics in locations across Lothian.

Mr Wynne added: “We continue to offer vaccination clinics across Lothian for anyone who requires a first dose of the vaccine, or who is now due their second dose. I would urge anyone who has still to be vaccinated to pop along.”

More information on the 12-15 vaccination programme is available on NHS Inform https://www.nhsinform.scot/12to15

Information on clinic locations and opening times is also available on NHS Lothian’s website – https://www.nhslothian.scot/Coronavirus/Vaccine/Pages/Drop-in-Clinics.aspx

Scotland’s 12 -15 year olds to be offered COVID-19 vaccination

And booster jag for adults from next Monday

Children and young people aged 12 -15 years old will be offered a dose of the coronavirus (COVID-19) vaccination from Monday (20 September) after Scottish Ministers accepted advice from the four UK Chief Medical Officers (CMOs).

As a result, a dose of Pfizer-BioNTech vaccine will be offered to all children and young people aged 12-15 who are not already covered by existing advice from the Joint Committee on Vaccination and Immunisation (JCVI) in a move to reduce the disruption caused to education by COVID-19.

This group will be offered their injections in drop-in clinics and community settings followed by each young person receiving a letter inviting them to attend a community clinic.

For some rural Health Boards, those aged 12 to 15 will first be offered the vaccine at school.

Following the initial phase, vaccines will be offered in both communities and schools so that anyone who hasn’t been vaccinated but would like to be has the opportunity to take up the offer.

Meanwhile, people who received their vaccination during phase one of the national COVID-19 vaccination programme in Scotland will start to receive booster injections from 20 September.

This follows advice from the JCVI which has advised that the booster dose can be given alongside the flu jab and should be offered no earlier than six months after completion of the primary vaccine course.

Frontline health and social care workers will be able to book their appointment online at NHS Inform from 20 September and from that date, residents in care homes for older people will be offered both flu and COVID-19 booster vaccination.

Adults aged 70 years and over and adults aged 16 years and over who are on the highest risk list (previously known as the shielding list) will be contacted soon, either by letter or by their GP. 

People on the highest risk list who were severely immunosuppressed at the time of their last COVID-19 vaccination will be offered a third primary dose instead. Other eligible groups – including all those aged 16 to 49 years with underlying health conditions, adult carers, unpaid and young carers, adult household contacts of immunosuppressed individuals and all adults over 50 – will be able to book online from October.

Health Secretary Humza Yousaf said: “I want to thank Dr Gregor Smith and the other three UK CMOs who have taken the time to consider the benefits of offering a first dose of the COVID-19 vaccination to 12-15 year olds.

“I recognise the impact disruption to education can have and am keen that we do all we can to reduce this so I am happy to accept the recommendation to proceed.

“As the CMOs recommended, informed consent must be at the heart of decision making so we will ensure that there is clear communication with this age group and their parents so they understand the potential benefits, potential side effects and the balance between them.

“A new leaflet from Public Health Scotland will be circulated to ensure parents, carers and young people have all the information they need. Individual choice is central to this, and the decisions of parents, carers and children will be respected.

“Alongside the booster programme this will be a busy period for our largest ever vaccination programme but work has been underway for some time to plan for this and I am confident our roll-out will continue to be a huge success.”

Statement given by the First Minister Nicola Sturgeon to the Scottish Parliament on Tuesday 14 September 2021

Thanks, Presiding Officer,

I will give an update today on the latest COVID situation.

I can confirm that the Cabinet met this morning, and decided not to make any immediate changes to the current regulations in place.

I will also give an update on certain other issues, most notably the mitigations in place for schools, including of course our approach to vaccination of 12 to 15 year olds, and the issue of a vaccine booster programme, which we have received final JVCI advice on this morning.

Firstly, though, to recap on today’s statistics.

3,375 positive cases were reported yesterday – 11.4% of all tests.

1,064 people are currently in hospital with COVID – 16 more than yesterday.

And 89 people are receiving intensive care – that is one fewer than yesterday.

Sadly, a further 21 deaths have been reported in the past 24 hours, and the total number of deaths under the daily definition is now 8,263.

And, as always, I send my condolences to everyone who has lost a loved one.

Good progress continues to be made in the vaccination programme.

As of this morning, 4,144,904 people have had a first dose and 3,788,551 have now had both doses.

95% of people over 40 are fully vaccinated with two doses now, as are 73% of 30-39 year olds, and 60% of 18 to 29 year olds.

Around 76% of 18-29 year olds have, though, had a first dose, so the proportion in that age group who become fully vaccinated will continue to increase in the weeks ahead.

In addition, 65% of 16 and 17 year olds have now had the first jag – which is five percentage points higher than at this time last week.

Presiding Officer,

Although the level of infection in Scotland remains too high, there are continuing signs that the recent spike in cases is now slowing down.

Indeed, we are now seeing early signs – not just that the rate of increase is slowing – but that cases are now actually starting to fall slightly.

This can be seen in the last three weeks’ data

In the week to 28 August, there were an average of 5,651 new cases a day – which was an increase of more than 80% on the previous week.

In the week to 4 September, average daily cases were 6,290 – still an increase, but one of just 11%.

However, in the seven days to 11 September – so the most recent seven-day period – cases have fallen to an average of 5,506 per day – which is 12% lower than last week.

It might also be worth providing some detail on the age breakdown of cases.

In the past week, more than 70% of cases have been in the under 45s.

And that’s consistent with the pattern we’ve seen throughout this latest wave.

However, the picture varies across different age groups – that said, there are broadly positive signs now in all of them.

Two weeks ago – in the week to 4 September – the number of cases in the 0-14 year old band rose by 51%. However in the past week, cases in that age group have fallen by 5%.

Amongst 15-24 year olds, cases fell by 16% two weeks ago, and have now fallen even further – by 34% – in the most recent week.

Two weeks ago, cases in the 25-44 year old age group rose by 7%, and last week, they fell by 14%.

Finally, the number of cases amongst the over 65s has risen slightly, but again the rate of increase has slowed down over the past week.

This most recent data underpinned Cabinet’s decision earlier today not to reintroduce any restrictions.

I am very grateful to everyone – organisations, businesses and individuals – who has taken extra care in recent weeks to try to stop this spike.

It does seem that these efforts are making a difference.

That said, of course, our position does remain challenging.

Even though new cases have fallen, they remain five times higher than at the start of August.

Universities are now returning for a new term. That is very welcome – but it also creates some additional risk, and I will say more shortly about how we are working to mitigate that risk.

Overall, though, the key point is this – the recent fall in cases is very welcome, but we cannot take it for granted. We must continue efforts to keep cases on a downward track.

The NHS is already under considerable pressure and any further rise in cases would intensify that.

As we know, vaccination has significantly weakened the link between cases of COVID and serious health harm from COVID.

The proportion of people with the virus who end up in hospital remains much lower now than before the vaccine programme started.

But current case numbers reflect how transmissible the Delta variant is.

So as we can see already – even a lower percentage of a large number of cases results in a high number of hospitalisations.

To illustrate that, on 20 August, there were 312 people in hospital with COVID. Today, there are 1,064.

The number in intensive care has also increased – from 34 on 20 August to 89 today.

Of course, these figures do not include people who don’t need hospital care, but nevertheless suffer long COVID.

It is also important to remember that the pressure that the NHS is experiencing falls on staff who have in many cases been working flat-out since the start of this pandemic.

And it comes at a time when the NHS is working to catch up on a backlog and care for everyone who needs it, not just COVID patients.

The Government continues to work closely with health boards to help manage these pressures.

But – as has been the case throughout the pandemic – everyone has a role to play.

At the start of the pandemic, we constantly emphasised the need to “protect our NHS”.

That is still necessary, and should give all of us even more incentive to get vaccinated, test regularly, and take all the basic precautions that we know can slow down transmission.

An additional reason for continued caution is that it helps protect those most at risk.

The UK Government announced earlier today that it will no longer use its Shielding Patient List.

In light of that – and to avoid any mistaken assumption – it’s important for us to confirm that the Scottish Government is not following suit at this stage. We will continue to use our equivalent list – which is the Highest Risk List.

We have used this throughout the pandemic to communicate with all those at highest risk and ensure that they have advice and support.

We will continue to keep this under review, but for the moment we believe it is important to retain it.

I will now provide a brief update on some specific strands of work.

Firstly, I can confirm that Cabinet Secretaries are continuing to engage with representatives from business, the public sector and wider civic society to encourage maximum compliance with the mitigations still in place.

I will be taking part in a roundtable meeting with a range of stakeholders immediately after this statement to underline the importance of this work.

I am, again, grateful to all businesses and organisations for the efforts being made to follow and promote measures like the wearing of face coverings; good ventilation and hygiene; and wherever possible, continued home working.

In addition, as I mentioned earlier the university term is now starting – colleges began their return a few weeks ago. And we have been working closely with universities, colleges and the wider sector to make the return as safe as possible.

As a precaution at this stage, colleges and universities won’t be holding large in-person lectures for now.

Instead, there will be a mix of online and in-person learning – with institutions themselves deciding the level of in-person teaching that they will offer during this term.

In addition, physical distancing will remain in place on campuses and face coverings will be required in indoor public spaces.

We are also – of course – encouraging students to get tested regularly. Test kits are available on campuses, and students who are moving to term-time accommodation should book a PCR test before making that move.

Above all, we are strongly encouraging students to get vaccinated if they haven’t done so already.

Mobile vaccination units are being deployed in universities and colleges during freshers’ weeks, and vaccination will continue to be made available throughout the term.

Health Board web pages will contain details of local drop-in clinics and also clinics operating within colleges or universities.

We are also continuing to work with local authorities to make schools and childcare centres as safe as possible – for example, though support for the use of carbon dioxide monitors and improved ventilation.

We have also received further advice from the Advisory sub-group on Education, and I want to take the opportunity today to highlight two points arising from that advice.

First, we indicated at the start of term that secondary schools pupils would need to wear face coverings in class for the first six weeks of term, subject to a review at that point.

Given the continuing high levels of infection still being experienced at this stage, the Advisory sub-group has advised that this requirement should remain in place until the October holidays, and be reviewed again then.

I know how unpopular this is with many pupils and I completely understand why.

But for now, it remains a prudent and a necessary precaution.

Second, we intend to clarify an aspect of guidance on contact tracing in schools, to help ensure fuller understanding of the process.

There is no change in advice for close contacts thought to be at high risk of having COVID. They will continue to be advised to self-isolate until they have returned a negative PCR test. For children and young people, a high-risk contact is most likely to be a household member, or someone they have stayed overnight with.

However, we will clarify guidance on the letters that schools send to lower-risk contacts. These letters should be sent on a targeted basis to those who are most likely to have had low risk contact with someone who has tested positive. They ensure that parents, staff and pupils are aware of those cases – and the letters offer advice on issues like looking out for symptoms, and using lateral flow testing.

Our updated guidance may mean, for example, that it is appropriate to send letters to the classmates of a pupil who has tested positive, but not necessarily to everyone in their year group.

We hope that better targeting will help reinforce the importance of the messages in these letters while minimising undue anxiety.

In addition, the advice in the letters will be strengthened in one respect.

They will recommend – to primary and secondary school pupils and staff who receive them – that a lateral flow test is taken before they next return to school. That test should be in addition to the regular twice weekly lateral flow testing which is recommended for all secondary school pupils and staff.

Presiding Officer,

All of these measures reflect our commitment to prioritising the wellbeing of children and young people – and our determination to minimise disruption to education.

That consideration was also, of course, central to the advice that the Scottish, Welsh, and UK Governments – and the Northern Irish Executive – received yesterday from our Chief Medical Officers.

Members will recall that the JCVI had concluded that the benefit of vaccination – the health benefit – for 12-15 year olds did outweigh any risks, but that because this was marginal they could not recommend a universal offer of vaccine to this age group on health grounds alone.

However, they indicated that it would be appropriate for Chief Medical Officers to consider whether any wider issues might tip the balance in the other direction.

The CMOs have now done so and concluded that vaccination could reduce disruption to education and that, taken together with the health benefits previously identified in the JCVI advice, extending the offer of vaccination to all 12 to 15 year olds is justified.

Taking this broader view of the benefits and risks of vaccination, the CMOs are recommending that 12 to 15 year olds should be offered one dose of the Pfizer vaccine.

This advice has been broadly endorsed by the Royal College of Paediatrics and Child Health.

I am very grateful to all of the four Chief Medical Officers for assessing the evidence on this issue with such pace and also with such rigour.

I can confirm to Parliament today that the Scottish Government welcomes and accepts this recommendation. We believe that vaccination of 12-15 year olds is important and we will therefore move to implement the advice as quickly as possible.

Our supplies of vaccine are adequate to allow us to do this.

It is, of course, important to stress how important informed consent is.

I know that many young people and their parents will have questions.

Material will be made available online later this week.

It will be appropriate to both young people and adults. It will seek to answer questions and provide balanced information to help young people and their parents make informed choices.

And I can confirm that from Monday 20 September, so Monday coming, drop in clinics will be open for any 12 – 15 year old who has read the information and – in discussion with parents and carers – decided that they do wish to be vaccinated.

It will of course be appropriate for parents or carers to accompany their children to clinics, and vaccinators will be on hand to answer any further questions or address any concerns.

And then, starting in the following week – so week beginning 27 September – letters will be sent to all 12 to 15 year olds inviting them to an appointment at a drop-in centre or vaccination clinic.

Again, parents and carers will be invited to accompany their children. And again the appointment will include an opportunity to ask questions and discuss concerns.

Finally, after the scheduled community sessions, there will be a programme of vaccination in schools, to ensure that anyone who hasn’t been vaccinated, and who decides that they want to be, gets a further opportunity.

Presiding Officer,

I know that these are important decisions for young people and their parents, and that many will have questions. I would encourage everyone to read the information that will be provided, and do not hesitate to visit a drop in clinic to ask any questions or raise any concerns.

Vaccination is a vital part of our overall protection against this virus. That is why it is important to support people – perhaps especially young people – to make informed choices that they feel comfortable with.

In addition to the CMO advice on 12-15 year olds, we have received this morning the final JCVI advice on a vaccine booster programme.

This is in addition to the third doses already being offered to people who were severely immunosuppressed or immunocompromised at the time of their first or second vaccination.

I can confirm that the Scottish Government is also accepting this advice, and again we have adequate supplies to move ahead with this.

The booster programme is intended to prolong the protection that vaccines provide against severe COVID illness.

It will run alongside our biggest ever flu vaccine programme – since, of course, both of these programmes are important for individual and for public health. Wherever possible, eligible people will be offered COVID and flu vaccines together.

Booster vaccines will be offered to all adults over 50; to frontline health and care workers; and to younger adults with certain health conditions that put them at higher risk; and to adult household contacts of people with suppressed immune systems. The JCVI has also advised that there should be an interval of at least six months between a second dose and a booster dose.

So let me now give a broad outline of the order in which we will now move to implement the booster programme. And of course we will set out more details shortly.

Frontline health and social care workers will be able to book their booster appointment online through NHS Inform from Monday 20 September – so that again is Monday coming.

Also from next week, residents in care homes for older people will be offered both flu and COVID booster vaccines.

Adults aged 70 or over, and everyone aged over 16 on the highest risk list will be contacted very shortly, either by letter or by their GP.

Other eligible groups – that’s all adults over 50, all those 16 to 49 with underlying health conditions, adult carers, unpaid and young carers, and adult household contacts of people who are immunosuppressed – will be able to book online from October.

These two announcements today, Presiding Officer, represent a very significant, and a very welcome, extension of the vaccine programme – and will help us considerably in our ongoing efforts against this virus.

So – to anyone eligible for vaccination – please do take up the opportunity.

The final point about vaccination I want to touch on very briefly is certification for certain venues – which, of course, Parliament approved in principle last week.

We are now working with businesses, events organisers and sports governing bodies to finalise the detail of the regulations and sector-specific guidance.

COVID certification has of course already been introduced in many countries across Europe. Indeed, many of them have already gone much further than we are proposing.

We know that this is not a magic wand – but we do believe that as part of a package of measures, it can help reduce transmission while keeping our economy and our society open, which is of course what all of us want to see.

Presiding Officer, I will close by emphasising again the key things all of us can do to help, and to ensure that we keep infections on a downward track.

Firstly, as I’ve already been talking extensively about – please get vaccinated if you are eligible and you haven’t yet done so.

Secondly, please continue to test yourself regularly with lateral flow devices. You can order these through NHS inform or collect them from a local test site or pharmacy.

And if you test positive, or you are identified as a close contact, or if you have symptoms of COVID, please self-isolate, and book a PCR test.

And thirdly and finally, please continue to comply with the mitigations still in place.

Please wear face coverings in indoor public places, such as shops, public transport and when moving about in hospitality settings.

Think carefully about the number of contacts you are having – and perhaps reduce any that are not strictly necessary.

Meet outdoors as much as possible.

Indoors, open windows if you can.

And, although it’s not the law anymore, try to keep a safe distance from people in other households – especially when you are indoors.

And remember to continue to wash your hands and surfaces thoroughly.

All of us this – as we can see in the most recent data – really does make a difference. So please stick with it and let’s get cases down even further.

Thank you, Presiding Officer.

Teaching union the EIS has welcomed the decision by the UK’s Chief Medical Officers (CMOs) that young people aged between 12 and 15 should be offered a COVID vaccination.

Infection rates have increased substantially in recent weeks, and we have seen record levels of both pupil and staff Covid related absences particularly amongst young people, as schools have returned. This is having a serious impact on education provision and has been a cause for concern for teachers and other school staff.

EIS General Secretary Larry Flanagan said, “The EIS welcomes this decision by the CMOs as the latest step in the battle against Coronavirus. Offering the vaccine to young people in the 12 to 15 age group will make secondary schools safer by reducing the risk of the virus spreading through school communities and will help reduce the level of disruption to education.

“Whilst we know that young people are less likely to become hospitalised through COVID, offering the vaccine will offer important additional protection against the virus.”

Mr Flanagan added, “In the few short weeks since our schools returned after the summer, we have already seen significant outbreaks in some school communities. This has led to an increase in enforced absences from school, with record numbers of students and staff forced to stay at home due to Coronavirus.

“Rolling out the availability of the vaccines to a wider group of young people will reduce the risk of further outbreaks linked to schools and help ensure that education provision can continue on as normal a basis as possible.”

School Safety Mitigations Extended

Safety mitigations to keep children, young people and staff safe in schools will be extended until at least the October holidays.

Education Secretary Shirley-Anne Somerville confirmed that all current mitigations, including the use of face coverings by pupils in secondary school classrooms, will still be required to help keep schools as safe as possible.

In addition, updated guidance will be provided in the information letters that schools are asked to send to staff and the parents of primary and secondary pupils when they are in low risk contact with positive cases in schools.

These will now include a strengthened recommendation to take a lateral flow test before returning to school. This is in addition to current advice for staff and secondary pupils to take a lateral flow test twice a week, with a few days apart, and record the result before returning to the classroom.

There will be a continued requirement for staff to keep at least a metre distance from each other and from children and young people when they are at schools.

Revised guidance to reflect these changes will be published as soon as possible.

Ms Somerville said: “Throughout this coronavirus pandemic, the safety of school pupils and staff has been my top priority. Every decision is underpinned by our determination to keep children and young people in schools when is safe to do so. 

“In light of the latest data and evidence, we have decided to extend the period for these mitigations to remain in place. This decision has been informed by expert medical advice and will be kept under close review to ensure it remains appropriate.

“We owe a debt of gratitude to our young people, for their continued compliance with the public health measures that keep us all safe. I promise that if we can remove the restrictions sooner, we will. For the moment though, we consider this an important protection for them, and for others in the school.”

Young people aged 12 to 15 to be offered a COVID-19 vaccine

  • Move follows unanimous advice to ministers from the four UK Chief Medical Officers
  • Parental consent will be sought prior to vaccination

People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine, following advice from the four UK Chief Medical Officers (CMOs), the Health and Social Care Secretary has announced. The Scottish Government is expected to make an announcement later today.

In line with the recommendation of the independent Joint Committee on Vaccination and Immunisation (JCVI), the government sought the views of the four UK CMOs on the wider issues that are relevant to the health of children.

The UK Government has accepted the advice of the four UK CMOs and the NHS is preparing to deliver a schools-based vaccination programme, which is the successful model used for vaccinations including for HPV and Diphtheria, Tetanus and Polio (DTP), supported by GPs and community pharmacies. Invitations for vaccination will begin next week.

Parental, guardian or carer consent will be sought by vaccination healthcare staff prior to vaccination in line with existing school vaccination programmes.

Healthy school-aged children aged 12 to 15 will primarily receive their COVID-19 vaccination in their school with alternative provision for those who are home schooled, in secure services or specialist mental health settings.

Health and Social Care Secretary, Sajid Javid said: “I have accepted the recommendation from the Chief Medical Officers to expand vaccination to those aged 12 to 15 – protecting young people from catching COVID-19, reducing transmission in schools and keeping pupils in the classroom.

“I am very grateful for the expert advice I have received from the Joint Committee on Vaccination and Immunisation and UK Chief Medical Officers.

“Our outstanding NHS stands ready to move forward with rolling out the vaccine to this group with the same sense of urgency we’ve had at every point in our vaccination programme.”

THE CHIEF MEDICAL OFFICERS’ LETTER READS:

To: Sajid Javid MP, Secretary of State for Health and Social Care, HM Government Eluned Morgan AS/MS, Minister for Health and Social Services, Welsh Government Humza Yousaf MSP, Cabinet Secretary for Health and Social Care, Scottish Government Robin Swann MLA, Minister of Health Northern Ireland Executive

13 September 2021

Dear Secretary of State, Cabinet Secretary and ministers,

Universal vaccination of children and young people aged 12 to 15 years against COVID-19

Background

The Joint Committee on Vaccination and Immunisation (JCVI) in their advice to you on 2 September 2021 on this subject said: ‘Overall, the committee is of the opinion that the benefits from vaccination are marginally greater than the potential known harms… but acknowledges that there is considerable uncertainty regarding the magnitude of the potential harms.

The margin of benefit, based primarily on a health perspective, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12 to 15-year-old children at this time…. JCVI is constituted with expertise to allow consideration of the health benefits and risks of vaccination and it is not within its remit to incorporate in-depth considerations on wider societal impacts, including educational benefits. The government may wish to seek further views on the wider societal and educational impacts from the Chief Medical Officers of the 4 nations, with representation from JCVI in these subsequent discussions.

Their full advice to you is appended in JCVI statement, September 2021: COVID-19 vaccination of children aged 12 to 15 years.

You accepted this recommendation from JCVI, and wrote to us on 2 September 2021 stating “We agree with the approach suggested by JCVI, and so we are writing to request that you take forward work (drawing on experts as you see fit) to consider the matter from a broader perspective, as suggested by the JCVI.”

The terms of reference (ToR) of this request, which the UK CMOs agreed, can be found in Terms of reference for UK CMO advice on universal vaccination of children and young people aged 12 to 15 years against COVID-19

In doing so we have been fortunate to have been informed by the independent expertise of leaders of the clinical and public health profession from across the UK. This has included Presidents and Chairs or their representative of:

  • Royal College of Paediatrics and Child Health
  • Royal College of General Practice
  • Royal College of Psychiatry
  • Faculty of Public Health
  • Academy of Medical Royal Colleges representing all the other Royal Colleges and Faculties
  • Association of Directors of Public Health
  • Regional Directors of Public Health
  • national public health specialists
  • experts in data and modelling

We are very grateful to them for taking considerable time and effort to consult their own colleagues in all 4 nations at short notice to get a comprehensive view of the balance of informed medical opinion and experience across the UK.

In addition, we have examined data from the Office for National Statistics as well as published data on the impact of COVID-19 on education, and other relevant published sources. We attach key published inputs in Key published inputs to the UK CMOs advice on universal vaccination of children and young people aged 12 to 15 years against COVID-19.

The UK’s independent regulator of medicines and vaccines the Medicines and Healthcare products Regulatory Agency (MHRA) is in law the appropriate body to determine whether, based on risk-benefit grounds, a vaccine is safe and effective to use and so grant a licence. They have done so for children and young people aged over 12 years for two vaccines against COVID-19, those manufactured by Pfizer and Moderna. Their assessment is that benefits exceed risks on an individual basis. We take their independent opinion as read. The MHRA position on mRNA vaccines is similar to the relevant regulatory approvals granted in the same age groups in multiple other jurisdictions including but not limited to the USA, the European Union, and Canada.

The independent JCVI is the proper body to give advice on how to deploy a vaccine which has a prior favourable risk-benefit decision and authorisation from MHRA including whether it has a sufficiently large benefit to be worth deploying on a larger, population scale. Like MHRA they consider the benefits of vaccination in this age group exceed the risks (i.e. it is better to be vaccinated than not vaccinated in this age group).

They balanced the risk of COVID-19 against the risks of vaccination, including myocarditis. When forming its advice, the JCVI considered vaccine use according to clinical risk groups, thus identifying different groups according to their potential to benefit from vaccination.

For 12 to 15 year olds who do not have underlying health conditions that place them at higher risk from severe COVID-19, the JCVI considered that the size of both the risk and the benefit are at an individual level very small, and the overall advantage for vaccination, whilst present, is therefore not sufficiently large to recommend universal vaccination on their usual criteria.

They deemed the extent to which vaccination might mitigate the impacts of COVID-19 on education was beyond the usual remit of the JCVI. They recognised however that given the substantial scale of the impact of COVID-19 on all children and young people, which goes beyond normal clinical benefit and risk, wider issues could, exceptionally, be relevant hence their suggestion to consult UK CMOs.

The JCVI have already recommended that children and young people aged 12 to 17 with specific underlying health conditions, and children and young people who are aged 12 years and over who are household contacts of persons who are immunocompromised are offered two doses of a vaccine, normally Pfizer BioNTech BNT162b2. They have recommended all young people 16 to 17 are offered an initial first dose of vaccine.

The UK has benefited from having data from the USA, Canada and Israel, which have already offered vaccines universally to children and young people aged 12 to 15.

The UK CMOs start from the position that the MHRA and JCVI set out on individual benefit-risk calculations for this age group, and have not revisited this. We accept that at an individual level benefit exceeds risk but this advantage is small, and we have taken the JCVI figures as the UK current position on this question.

The Chair of the JCVI Prof. Lim has been a member of our group to ensure that there is no duplication of effort or conflict between the views of UK CMOs and the JCVI. We have been fortunate to have been joined also by the lead Deputy Chief Medical Officers for vaccines Prof. Van Tam (England), Prof. Steedman (Scotland) and Dr. Chada (Northern Ireland) and the DHSC Chief Scientific Adviser, Prof. Chappell. The final advice is that of the Chief Medical Officers, but informed by independent senior clinical and public health input from across the UK.

UK CMOs have decided in their ToR that we will only consider benefits and disbenefits to those aged 12 to 15 from vaccinating this age group, including indirect benefits. Whilst there may be benefits to other age groups, these have not been considered in our advice below.

Issues of vaccine supply were not factors considered in decision making.

The UK CMOs are aware of the extensive range of non-clinical views but this UK CMOs advice is purely clinical and public health derived and has not taken issues outside their clinical and public health remit into account. There is a subsequent political process where wider societal issues may be considered by ministers in deciding how they respond to this advice.

Advice

All drugs, vaccines and surgical procedures have both risks and benefits. If the risks exceed benefits the drug, vaccine or procedure should not be advised, and a drug or vaccine will not be authorised by MHRA. If benefits exceed risks then medical practitioners may advise the drug or vaccine, but the strength of their advice will depend on the degree of benefit over risk.

At an individual level, the view of the MHRA, the JCVI and international regulators is that there is an advantage to someone aged 12 to 15 of being vaccinated over being unvaccinated. The COVID-19 Delta variant is highly infectious and very common, so the great majority of the unvaccinated will get COVID-19. In those aged 12 to 15, COVID-19 rarely, but occasionally, leads to serious illness, hospitalisation and even less commonly death. The risks of vaccination (mainly myocarditis) are also very rare. The absolute advantage to being vaccinated in this age group is therefore small (‘marginal’) in the view of the JCVI. On its own the view of the JCVI is that this advantage, whilst present, is insufficient to justify a universal offer in this age group. Accepting this advice, UK CMOs looked at wider public health benefits and risks of universal vaccination in this age group to determine if this shifts the risk-benefit either way.

Of these, the most important in this age group was impact on education. UK CMOs also considered impact on mental health and operational issues such as any possible negative impact on other vaccine programmes, noting that influenza vaccination and other immunisations of children and young people are well-established, important, and that the annual flu vaccine deployment programme commences imminently.

The UK CMOs, in common with the clinical and wider public health community, consider education one of the most important drivers of improved public health and mental health, and have laid this out in their advice to parents and teachers in a previous joint statement. Evidence from clinical and public health colleagues, general practice, child health and mental health consistently makes clear the massive impact that absent, or disrupted, face-to-face education has had on the welfare and mental health of many children and young people. This is despite remarkable efforts by parents and teachers to maintain education in the face of disruption.

The negative impact has been especially great in areas of relative deprivation which have been particularly badly affected by COVID-19. The effects of missed or disrupted education are even more apparent and enduring in these areas. The effects of disrupted education, or uncertainty, on mental health are well recognised. There can be lifelong effects on health if extended disruption to education leads to reduced life chances.

Whilst full closures of schools due to lockdowns is much less likely to be necessary in the next stages of the COVID-19 epidemic, UK CMOs expect the epidemic to continue to be prolonged and unpredictable. Local surges of infection, including in schools, should be anticipated for some time. Where they occur, they are likely to be disruptive.

Every effort should be taken to minimise school disruption in policy decisions and local actions. Vaccination, if deployed, should only be seen as an adjunct to other actions to maintain children and young people in secondary school and minimise further education disruption and therefore medium and longer term public health harm.

On balance however, UK CMOs judge that it is likely vaccination will help reduce transmission of COVID-19 in schools which are attended by children and young people aged 12 to 15 years. COVID-19 is a disease which can be very effectively transmitted by mass spreading events, especially with Delta variant. Having a significant proportion of pupils vaccinated is likely to reduce the probability of such events which are likely to cause local outbreaks in, or associated with, schools. They will also reduce the chance an individual child gets COVID-19. This means vaccination is likely to reduce (but not eliminate) education disruption.

Set against this there are operational risks that COVID-19 vaccination could interfere with other, important, vaccination programmes in schools including flu vaccines.

Overall however the view of the UK CMOs is that the additional likely benefits of reducing educational disruption, and the consequent reduction in public health harm from educational disruption, on balance provide sufficient extra advantage in addition to the marginal advantage at an individual level identified by the JCVI to recommend in favour of vaccinating this group.

They therefore recommend on public health grounds that ministers extend the offer of universal vaccination with a first dose of Pfizer-BioNTech COVID-19 vaccine to all children and young people aged 12 to 15 not already covered by existing JCVI advice.

If ministers accept this advice, UK CMOs would want the JCVI to give a view on whether, and what, second doses to give to children and young people aged 12 to 15 once more data on second doses in this age group has accrued internationally. This will not be before the spring term.

In recommending this to ministers, UK CMOs recognise that the overwhelming benefits of vaccination for adults, where risk-benefit is very strongly in favour of vaccination for almost all groups, are not as clear-cut for children and young people aged 12 to 15. Children, young people and their parents will need to understand potential benefits, potential side effects and the balance between them.

If ministers accept this advice, issues of consent need to take this much more balanced risk-benefit into account. UK CMOs recommend that the Royal Colleges and other professional groups are consulted in how best to present the risk-benefit decisions in a way that is accessible to children and young people as well as their parents. A child-centred approach to communication and deployment of the vaccine should be the primary objective.

If ministers accept this advice, it is essential that children and young people aged 12 to 15 and their parents are supported in their decisions, whatever decisions they take, and are not stigmatised either for accepting, or not accepting, the vaccination offer. Individual choice should be respected.

Chief Medical Officer for England Prof. Christopher Whitty

Chief Medical Officer for Northern Ireland Sir Michael McBride

Chief Medical Officer for Scotland Dr. Gregor Smith

Chief Medical Officer for Wales Dr. Frank Atherton

Over four in five adults across the UK have received both COVID-19 vaccine doses, with over half of all 16 and 17 year olds coming forward for their first jab.

However COVID numbers continue to rise across the UK. 28,856 new cases were reported yesterday, with 4241 of these in Scotland. The daily Scottish figure is likely to be considerably higher due to an IT problem.

Responding to the advice from the Chief Medical Officers regarding the vaccination of all 12-15 year olds, Bruce Adamson, the Children and Young People’s Commissioner Scotland, said:  “We welcome the advice to offer the vaccine to children between the age of 12 and 15. It is important to give them that choice.  

“Children and young people have a right to the best possible health, that’s not just about protection from the Covid virus itself, but also the impact on their mental health due to isolation and other factors. The pandemic has impacted their right to education, their right to play, their right to see wider family and friends which is so essential to their development. Their education has been disrupted with two long periods of school closures. 

“It is important that children are supported to make informed decisions about their own health. Children of this age group have told me over the last few months that they are in favour of having the choice to be vaccinated. That is not to say that all of them had made a decision about whether they would get a vaccine, but they wanted the option to be available to them. Of course, there have been some children who are concerned about vaccination, or who told me about parental concerns. It is important that there is no stigma attached to the choices that children make about vaccination. 

“It is essential that this advice is communicated directly to 12 to 15 year olds in a child-friendly way so they can understand why they are now being offered the vaccine, and can have any questions they might have answered in a way they can understand. Children have the right to access appropriate information on decisions affecting them.  

“Parents and carers will play an important role in supporting the decision-making around whether a child chooses to get vaccinated so it is important that they have all of the necessary information to support that choice.” 

Prime Minister to set out next steps in Covid response

Boris Johnson will set out the UK Government’s autumn and winter plan for managing Covid this week

  • Government focus to remain on vaccines as the first line of defence over the autumn and winter months
  • JCVI final ‘booster’ decision expected this week
  • Measures from the Coronavirus Act expected to be repealed

Prime Minister Boris Johnson will this week set out the UK Government’s autumn and winter plan for managing Covid.

Vaccines will continue to be our first line of defence over the autumn and winter months supported by new treatments, testing, and a world leading variant surveillance system.

Due to the efforts and sacrifices of the public, our NHS, and the phenomenal success of the vaccine rollout, the vast majority of restrictions were lifted in England at Step 4 of the Roadmap on 19 July.

As of 9 September, nearly 90% of the UK population aged over 16 have received a first dose of the Covid vaccine, and over 80% have received both doses.

The latest data from Public Health England shows Covid vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant, the dominant strain in the UK. Analysis shows the Pfizer-BioNTech vaccine is 96% effective and the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after two doses.

The winter months will bring renewed challenges. Covid will circulate alongside flu and other respiratory viruses and the threat of a new variant remains. It is difficult to predict with certainty how these will interact and what pressure they may place on the NHS.

The independent expert committee – the Joint Committee on Vaccinations and Immunisation (JCVI) – were asked to consider a Covid vaccine booster programme. Their interim advice suggested planning for booster vaccines to be rolled out to the most vulnerable from September 2021, to offer an increased level of protection over winter.

The government expects to receive confirmation this week from the JCVI on the details of a vaccination booster programme, with plans in place to begin this month. This will boost immunity over the winter months, protecting against serious disease and death and unsustainable pressure on the NHS.

The government confirmed last week that those who are immunocompromised will be offered a third primary dose. This is separate to the booster programme, as those who require a third primary dose had insufficient protection from two doses.

The Prime Minister is also expected to repeal powers in England that are no longer necessary from the Coronavirus Act, as part of the government’s plan for managing Covid over the autumn and winter.

These include:

  • Powers to close-down sectors of the economy, such as business premises, or apply restrictions to events and gatherings.
  • Powers that disrupt education, enabling temporary closure or restricting access to schools, colleges, and childcare.
  • Powers that extend time limits for urgent warrants. Powers to detain infectious people.

Vital powers from the Act will be retained that are critical to protect and support the public. This includes giving sick pay to those isolating from day one rather than day seven, directing schools to remain open if they close against government guidance, and helping the NHS to get the emergency resource it needs.

Legal requirements will remain for someone to isolate if they test positive, to protect the most vulnerable from infection and to control the spread of variants. The Coronavirus Act is separate from the Public Health Act.

The Prime Minister is expected to hold a press conference this week – perhaps as early as tomorrow – to set out the next steps in the pandemic response.

Prime Minister, Boris Johnson said: “Thanks to the efforts of the public, the NHS and our phenomenal vaccination programme, we reached Step 4 in our Roadmap and life has returned to a sense of normality.

“These extraordinary times required necessary but intrusive measures. But I’m determined to get of rid of any powers we no longer need because of our vaccine defences.

“I will set out the next phase in our Covid response shortly.”

PM Boris Johnson is pictured during a Downing Street homecoming reception for the GB Paralympic team.

Three new mobile vaccination buses target Scotland’s students

The Scottish Ambulance Service has launched three new mobile vaccination buses to cover the whole of Scotland – with a bus dedicated to the east, west and north of the country.

Over the last seven months, the Service has been working in partnership with health boards and local authorities to support the delivery of the national vaccination programme. With the launch of the new buses, one of the key priorities will be to ensure that students are able to access vaccines.

There will be further clinics at the University of the West of Scotland, Paisley, Glasgow Caledonian University and Glasgow University, where it will be parked up at different locations including Murano Street.

The east bus will be at locations in the Scottish Borders, including at Borders College in September, while the north bus will be working with secondary schools across the Highlands.

Pauline Howie, Chief Executive of the Scottish Ambulance Service, said: “Our fantastic staff and our close working with Scottish Government, Health Boards and local authorities across Scotland has meant we can reach into communities via our mobile vaccination bus to ensure everyone has the chance to be vaccinated.

“With university students set to arrive on campuses across the country, we want to ensure they are protected, so over the coming months our vaccination buses will be located at universities and campuses to ensure every student can protect themselves, and others, from Covid-19.”

Health Secretary Humza Yousaf said: “These new vaccine buses, along with those being run by some NHS boards, makes it even easier for students to get vaccinated. As well as going round schools in the Highlands, they will also visit university and college campuses around Scotland Earlier this year we announced the international students will also be included in our national programme.

“The increase in case numbers in recent weeks means it remains vital everyone who is offered a vaccine takes up the invitation. The vaccine buses has been an excellent addition to our national vaccination programme and I want to say a huge thank you to everyone involved for their hard work.”

Gillian Plunkett, Director for Student Experience at City of Glasgow College, said: “Throughout this global pandemic the health and welfare of our students has been our top priority. We are delighted to welcome the NHS Mobile Vaccination Unit. It offers immediate access for students and staff who have still to receive their first vaccine, or their second dose.  

“While we continue with our hybrid learning and teaching approach this new academic year, we are encouraging our students to take up the vaccine which is strongly recommended by the NHS as providing the best protection against the effects of Covid-19.”  

The mobile vaccination buses will also be helping communities across Scotland, so that everyone can receive the appropriate Covid 19 vaccines for their age group. New funding has been provided by the Scottish Government for the buses, in order to improve accessibility to vaccine clinics across the country.

Second doses offered to all eligible adults in Scotland

Missed appointments can be rearranged

Scotland’s largest ever vaccination programme will complete second doses for all over 18s who have attended their scheduled appointments by close of play on Sunday 12 September.

Some of those eligible have rearranged their appointment for health or work reasons and will get their second dose shortly. Vaccination Clinics will remain open and anyone who has not yet received their vaccination, for whatever reason is reminded that it is never too late to get vaccinated and is urged to go to a local drop-in clinic or go to NHS Inform to book a convenient appointment.

The second dose of the vaccine offers greater and longer lasting protection and can be given from eight weeks after the first, either at a drop-in clinic or by requesting an appointment through the NHS Inform website.

Evidence shows that after two doses the vaccines are more than 90% effective against hospital admissions from the effects of the virus.

Students from the UK and abroad are included in the national programme and are encouraged to come forward for vaccination regardless of whether they require their first, second or both doses.

Health Secretary Humza Yousaf said: “Today is a significant day because every single adult in Scotland has now been given the opportunity to be fully vaccinated against COVID-19.

“I want to pass on my thanks to all those who have helped make this possible – from the scientists who developed the vaccine, to the hard-working staff delivering the programme on the ground. I also want to thank everyone who has taken up their offer of a vaccine, and rolled up their sleeves to help tackle coronavirus.

“To all those who haven’t yet had their second doses, please don’t leave the job half done.  Even if the time since the first dose is more than eight weeks, people can still be vaccinated and I encourage them to come forward.

“We have made getting a vaccination easier than ever – head to one of the drop-in clinics being offered across the country or, if you prefer, book an appointment online at NHS Inform. Please check your NHS board’s social media posts for the latest information on where you can attend.

“Students heading to university or college from anywhere in the UK or abroad are reminded they too are urged to take up this offer if it’s relevant to them – indeed, in addition to drop-in clinics around the country, mobile vaccination units are visiting several further education campuses.

“Recent increases in case numbers mean it remains crucial everyone who is offered a vaccination takes up the invitation.”

Rearrange a vaccination appointment

Information on drop-in clinics